Posted in | News | Materials Analysis

Malvern Panalytical and Micromeritics Instruments Announce Collaborative Partnership

Micromeritics Instruments and Malvern Panalytical have today announced a new collaborative sales partnership. This strategic relationship brings together two highly respected, market-leading instrument providers to offer customers an extensive and effective combined solution approach for materials and particle characterization. In several key markets around the world, Micromeritics will serve as a non-exclusive distributor for the World’s most widely used Dynamic Light Scattering (DLS) and Zeta Potential measurement systems, Malvern Panalytical’s Zetasizer range. This will ultimately help drive customer innovation by helping to improve the performance of both products and processes.

Malvern Panalytical’s Zetasizer Ultra - Advance with Confidence (Credit: Malvern Panalytical)

“Collaborating with a progressive innovator and highly respected leader such as Malvern Panalytical aligns with our strategic development to deliver greater value in analytical instrument solutions for our customers,” said Preston Hendrix, President of Micromeritics Instruments. “Micromeritics has always put our customers’ interests first, and this partnership is further proof of that commitment to deliver excellence in materials characterization.”

Paolo Carmassi, President of Malvern Panalytical, also highlighted the importance of this collaboration in supporting customers and commented that “access to critical analytical data is essential to generating the insight required to enable rapid, cost-effective development of innovative new materials, products and processes. Our partnership with Micromeritics will assist scientists and engineers in obtaining this critical data, bringing increased tangible value to our customers and growing our capability to effectively support applications we currently do not serve.”

This announcement follows the recent acquisitions by Micromeritics of Freeman Technology Corporation, Ltd (Gloucestershire, UK) and Process Integral Development S.L. (Madrid, Spain), providing capabilities for process and product optimization across a wide variety of applications. The Zetasizer distribution agreement further adds to this capability, providing support for the development of novel nanomaterials.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2018, September 10). Malvern Panalytical and Micromeritics Instruments Announce Collaborative Partnership. AZoM. Retrieved on February 26, 2024 from

  • MLA

    Malvern Panalytical. "Malvern Panalytical and Micromeritics Instruments Announce Collaborative Partnership". AZoM. 26 February 2024. <>.

  • Chicago

    Malvern Panalytical. "Malvern Panalytical and Micromeritics Instruments Announce Collaborative Partnership". AZoM. (accessed February 26, 2024).

  • Harvard

    Malvern Panalytical. 2018. Malvern Panalytical and Micromeritics Instruments Announce Collaborative Partnership. AZoM, viewed 26 February 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.